Geron (GERN) Revenue (2010 - 2026)
Geron (GERN) posted Revenue of $51.8 million for Q1 2026, up 139.27% sequentially from -$132.0 million in Q4 2025, and up 30.89% YoY from $39.6 million in Q1 2025.
Geron (GERN) Revenue (2010 - 2026) Analysis & Trends
Geron has reported Revenue for 17 years, with the latest figure at $51.8 million in Q1 2026.
- Quarterly Revenue rose 30.89% year-over-year to $51.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.1 million (down 59.59% YoY) and the FY2025 annual result came in at $3.8 million, up 671.34% from the prior year.
- Revenue grew to $51.8 million in Q1 2026 per GERN's latest filing, from -$132.0 million in the prior quarter.
- Over five years, Revenue peaked at $51.8 million in Q1 2026 and troughed at -$132.0 million in Q4 2025.
- A 5-year average of $3.3 million and a median of $164000.0 in 2023 frame the typical range for Revenue.
- The widest YoY moves for Revenue: up 17138.41% in 2024, down 13431.78% in 2024.
- Over 5 years, Revenue stood at $103000.0 in 2022, then plunged by 307.77% to -$214000.0 in 2023, then slumped by 13431.78% to -$29.0 million in 2024, then slumped by 355.89% to -$132.0 million in 2025, then jumped by 139.27% to $51.8 million in 2026.
- According to Business Quant data, Revenue over the past three periods registered $51.8 million, -$132.0 million, and $47.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.29 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.06 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 425.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 674.14 Mn |
| 10 | Geron | 1.02 Mn | -299.83 Mn | - | 57.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 57.48 Mn |
| Mar 31, 2026 | 51.84 Mn |
| Dec 31, 2025 | -132.02 Mn |
| Sep 30, 2025 | 47.23 Mn |
| Jun 30, 2025 | 49.04 Mn |
| Mar 31, 2025 | 39.60 Mn |
| Dec 31, 2024 | -28.96 Mn |
| Sep 30, 2024 | 28.27 Mn |
| Jun 30, 2024 | 882,000.00 |
| Mar 31, 2024 | 304,000.00 |
| Dec 31, 2023 | -214,000.00 |
| Sep 30, 2023 | 164,000.00 |
| Jun 30, 2023 | 29,000.00 |
| Mar 31, 2023 | 21,000.00 |
| Dec 31, 2022 | 103,000.00 |
| Sep 30, 2022 | 297,000.00 |
| Jun 30, 2022 | 73,000.00 |
| Mar 31, 2022 | 123,000.00 |
| Dec 31, 2021 | 1.04 Mn |
| Sep 30, 2021 | 109,000.00 |